Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.

Taurine, a non essential sulfur-containing amino acid, plays a critical role in cardiovascular functions. We here examined the effect of taurine on angiogenesis and its underlying signal pathway. Taurine treatment increased angiogenesis in vitro and in vivo, which was followed by activation of the phosphatidylinositol 3-kinase (PI3K)/Akt, MEK/ERK, and Src/FAK signaling pathways. Further, taurine promoted endothelial cell cycle progression to the S and G2/M phases by up-regulating the positive cell cycle proteins, particularly cyclins D1 and B, as well as down-regulating the negative cell cycle proteins, p53 and p21(WAF1/CIP1), resulting in Rb phosphorylation. This angiogenic event was inhibited by inhibitors of PI3K and MEK. In addition, a PI3K inhibitor blocked the activation of Akt and ERK, while Akt knockdown did not affect taurine-induced ERK activation, indicating that PI3K is an upstream mediator of both MEK and Akt. Taurine-induced endothelial cell migration was suppressed by Src inhibitor, but not by other inhibitors, suggesting that the increase in cell migration is regulated by Src-dependent pathway. Moreover, inhibition of cellular taurine uptake by β-alanine and taurine transporter knockdown promoted taurine-induced cell proliferation, ERK and Akt activation, and in vivo angiogenesis, suggesting that extracellular taurine induces angiogenesis. However, taurine did not induce vascular inflammation and permeability in vitro and in vivo. These data demonstrate that extracellular taurine promotes angiogenesis by Akt- and ERK-dependent cell cycle progression and Src/FAK-mediated cell migration without inducing vascular inflammation, indicating that it is potential use for the treatment of vascular dysfunction-associated human diseases.

[1]  N. Usuda,et al.  Immunohistochemical localization of taurine in various tissues of the mouse , 2005, Amino Acids.

[2]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[3]  Hyung Jin Kim,et al.  Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[4]  S. Eguchi,et al.  Mechanism of Endothelial Nitric Oxide Synthase Phosphorylation and Activation by Thrombin , 2007, Hypertension.

[5]  Jian Yu,et al.  Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis , 2009, Oncogene.

[6]  Geng-Hung Liu,et al.  p21 stability: linking chaperones to a cell cycle checkpoint. , 2005, Cancer cell.

[7]  K. Arakawa,et al.  Taurine amplifies renal kallikrein and prevents salt‐induced hypertension in Dahl rats , 1994, Journal of hypertension.

[8]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[9]  C. Winterbourn,et al.  Extracellular Oxidation by Taurine Chloramine Activates ERK via the Epidermal Growth Factor Receptor* , 2004, Journal of Biological Chemistry.

[10]  F. Hanaoka,et al.  Transcription of the catalytic 180-kDa subunit gene of mouse DNA polymerase alpha is controlled by E2F, an Ets-related transcription factor, and Sp1. , 2000, Biochimica et biophysica acta.

[11]  Tapan M. Bhavsar,et al.  Protective action of taurine, given as a pretreatment or as a posttreatment, against endotoxin-induced acute lung inflammation in hamsters , 2010, Journal of Biomedical Science.

[12]  D. Friedman,et al.  Construction of a Cyclin D1-Cdk2 Fusion Protein to Model the Biological Functions of Cyclin D1-Cdk2 Complexes* , 2004, Journal of Biological Chemistry.

[13]  J. Massagué,et al.  Cyclins, Cdks, and cyclin kinase inhibitors. , 1994, Cold Spring Harbor symposia on quantitative biology.

[14]  L. Favot,et al.  Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4 , 2004, Thrombosis and Haemostasis.

[15]  H. Satoh,et al.  Modulation by taurine of human arterial stiffness and wave reflection. , 2009, Advances in experimental medicine and biology.

[16]  Y. Ho,et al.  Inhibition of the ERK phosphorylation plays a role in terbinafine-induced p21 up-regulation and DNA synthesis inhibition in human vascular endothelial cells. , 2008, Toxicology and applied pharmacology.

[17]  Marielle Afanassieff,et al.  Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells , 2002, Oncogene.

[18]  R. Chesney,et al.  Studies on renal adaptation to altered dietary amino acid intake: tissue taurine responses in nursing and adult rats. , 1986, The Journal of nutrition.

[19]  N. Sperelakis,et al.  Review of some actions of taurine on ion channels of cardiac muscle cells and others. , 1998, General pharmacology.

[20]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[21]  J. Das,et al.  Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. , 2009, Toxicology and applied pharmacology.

[22]  Y. Yamori,et al.  Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats. , 1996, Life sciences.

[23]  F. Fennessy,et al.  Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers , 2003, Circulation.

[24]  J. Pouysségur,et al.  Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.

[25]  J. Gutkind,et al.  VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin , 2006, Nature Cell Biology.

[26]  Paul Nurse,et al.  Ordering S phase and M phase in the cell cycle , 1994, Cell.

[27]  R. Chesney,et al.  The Relative Roles of External Taurine Concentration and Medium Osmolality in the Regulation of Taurine Transport in LLC-PK1 and MDCK Cells , 1995, Pediatric Research.

[28]  H. Redmond,et al.  THE BENEFICIAL EFFECT OF TAURINE ON THE PREVENTION OF HUMAN ENDOTHELIAL CELL DEATH , 1996, Shock.

[29]  A. Mantovani,et al.  Molecular mechanisms of blood vessel formation. , 1997, Trends in biochemical sciences.

[30]  Yoon Kyung Choi,et al.  The Farnesyltransferase Inhibitor LB42708 Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signal Pathways , 2010, Molecular Pharmacology.

[31]  F. Fennessy,et al.  Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. , 1999, American journal of physiology. Cell physiology.

[32]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[33]  Young Chul Kim,et al.  Taurine depletion by beta-alanine inhibits induction of hepatotoxicity in mice treated acutely with carbon tetrachloride. , 2009, Advances in experimental medicine and biology.

[34]  S. Messina,et al.  Effects of high salt diets and taurine on the development of hypertension in the stroke-prone spontaneously hypertensive rat , 2000, Amino Acids.

[35]  M. Tagawa,et al.  Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma. , 2010, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[36]  K. Ha,et al.  Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. , 2006, American journal of physiology. Heart and circulatory physiology.

[37]  D. Bouchier-Hayes,et al.  Taurine Attenuates Acute Hyperglycaemia-Induced Endothelial Cell Apoptosis, Leucocyte-Endothelial Cell Interactions and Cardiac Dysfunction , 2006, Journal of Vascular Research.

[38]  T. Terasaki,et al.  Function and regulation of taurine transport at the inner blood-retinal barrier. , 2007, Microvascular research.

[39]  N. Rosen,et al.  Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 1998, The Journal of Biological Chemistry.

[40]  Sun Choi,et al.  Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. , 2008, Cancer research.